Skip to content

Investigating the effect of using cinnamon supplements on IVF cycle results in infertile women with polycystic ovary syndrome

The effect of cinnamon supplementation on infertility treatment outcomes in infertile women with polycystic ovary syndrome (PCOS) candidate of in vitro-fertilization (IVF): A pilot double blind randomized controlled clinical trial

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20080831001141N44
Enrollment
80
Registered
2023-10-30
Start date
2023-11-21
Completion date
Unknown
Last updated
2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Polycystic ovarian syndrome. Polycystic ovarian syndrome

Interventions

Intervention 1: Intervention group: patients will take 1500 mg daily (3 tablets of cinnamon 500 mg, Sagepad Darou Pharmaceutical Company, Iran) that is, 4 weeks before the start of the new IVF cycle a

Sponsors

Lotus Royan Charitable Fundation
Lead Sponsor
Sagepad Darou Company
Collaborator

Eligibility

Sex/Gender
Female
Age
18 Years to 38 Years

Inclusion criteria

Inclusion criteria: Infertile women with polycystic ovary syndrome (PCOS) diagnosed according to the Rotterdam criteria who meet at least 2 of the following three criteria including: (1) oligomenorrhea or anovulation, (2) hyperandrogenism (clinical or biochemical ng/ dL 80 = serum T level), (3) the presence of polycystic ovaries in ultrasound). The age range of 18 to 38 year. Written consent to participate in the study

Exclusion criteria

Exclusion criteria: Body mass index above 35 kg/m2 Endocrine disorders including diabetes mellitus, hyperprolactinemia, hypertension, Cushing's syndrome Autoimmune disorders History of recurrent pregnancy loss Genital, ovarian or uterine abnormalities Hydrosalpinx diagnosis Congenital adrenal hyperplasia, androgen-producing tumors or acromegaly Sensitivity to cinnamon Daily and frequent consumption of cinnamon to treat infertility Severe male factor infertility Moderate to severe endometriosis diagnosis Use of other hypoglycemic, insulin-sensitizing drugs (e.g. Metformin) or other antioxidant supplement (e.g. Myo-inositol) and ß-blocker before or during the study

Design outcomes

Primary

MeasureTime frame
Total number of retrieved oocytes. Timepoint: Day of oocyte pick-up, 32-34 hours after hCG administration (approximately day 10 of ovarian stimulation). Method of measurement: At the point of ovum pick-up, the total number of retrieved oocytes is counted by the embryologist. Therefore, it will be possible to measure the results one hour after oocytes retrieval.;Total number of mature (MII) oocytes. Timepoint: Day of oocyte pick-up, 32-34 hours after hCG administration (approximately day 10 of ovarian stimulation). Method of measurement: At the point of ovum pick-up, the total number of retrieved oocytes is counted by the embryologist. Therefore, it will be possible to measure the results one hour after oocytes retrieval.;Oocyte recovery ratio. Timepoint: Day of oocyte pick-up, 32-34 hours after hCG administration (approximately day 10 of ovarian stimulation). Method of measurement: This ratio is obtained by dividing the total number of retrieved oocytes by the total number of aspirated follicles from both ovaries.;Oocyte maturity rate. Timepoint: Day of oocyte pick-up, 32-34 hours after hCG administration (approximately day 10 of ovarian stimulation). Method of measurement: This ratio is calculated by dividing the number of mature oocytes (MII) obtained by the total number of retrieved oocytes from both ovaries.

Secondary

MeasureTime frame
PI3K gene expression relative to the housekeeping gene. Timepoint: 6 weeks after taking cinnamon supplements (oocyte retrieval day). Method of measurement: After collecting follicular fluid on the day of oocyte retrieval, granulosa cells are extracted from the follicular fluid using a density gradient method. RNA is extracted from the cells using a column kit and converted to complementary DNA (cDNA). Then, gene expression is assessed relative to a control gene using real-time PCR.;CYP19A1 gene expression relative to the housekeeping gene. Timepoint: 6 weeks after taking cinnamon supplements (oocyte retrieval day). Method of measurement: After collecting follicular fluid on the day of oocyte retrieval, granulosa cells are extracted from the follicular fluid using a density gradient method. RNA is extracted from the cells using a column kit and converted to complementary DNA (cDNA). Then, gene expression is assessed relative to a control gene using real-time PCR.;Calpain10 ?gene expression relative to the housekeeping gene. Timepoint: 6 weeks after taking cinnamon supplements (oocyte retrieval day). Method of measurement: After collecting follicular fluid on the day of oocyte retrieval, granulosa cells are extracted from the follicular fluid using a density gradient method. RNA is extracted from the cells using a column kit and converted to complementary DNA (cDNA). Then, gene expression is assessed relative to a control gene using real-time PCR.;Fertilization rate. Timepoint: 17-18 h after intracytoplasmic sperm injection and/or in-vitro insemination by checking the number of polar bodies and pronuclei. Method of measurement: The fertilization rate is defined as the ratio between the number of diploid zygotes and the number of mature oocytes.;Quality of obtained embryos. Timepoint: 3 days after intracytoplasmic sperm injection or in vitro fertilization (IVF/ICSI) procedure. Method of measurement: Embryo grade is assessed under an inverted microscope 3 days after the

Countries

Iran (Islamic Republic of)

Contacts

Public ContactZeynab Siahnouri

Royan Institute

zeynab.nouri@yahoo.com+98 21 2356 2640

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026